Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
Search
Close this search box.
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
Menu
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation

  • Post author:
  • Post published:June 7, 2025
  • Post category:

The objective of this study is to develop a new, optimized technology to obtain a homogenous population of midbrain dopaminergic (mDA) neurons in a culture dish through neuronal differentiation. Dopaminergic…

Continue ReadingSite-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation

Inhibitory Nerve Cell Precursors: Dosing, Safety and Efficacy

  • Post author:
  • Post published:June 7, 2025
  • Post category:

Many neurological disorders are characterized by an imbalance between excitation and inhibition. Our ultimate goal: to develop a cell-based therapy to modulate aberrant brain activity in the treatment of these…

Continue ReadingInhibitory Nerve Cell Precursors: Dosing, Safety and Efficacy

Neural restricted, FAC-sorted, human neural stem cells to treat traumatic brain injury

  • Post author:
  • Post published:June 7, 2025
  • Post category:

Traumatic brain injury (TBI) affects 1.4 million Americans a year; 175,000 in California. When the brain is injured, nerve cells near the site of injury die due to the initial…

Continue ReadingNeural restricted, FAC-sorted, human neural stem cells to treat traumatic brain injury

Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons

  • Post author:
  • Post published:June 7, 2025
  • Post category:

Injuries to the spinal cord commonly result from motor vehicle accidents, traumatic falls, diving, surfing, skiing, and snowboarding accidents, other forms of sports injuries, as well as from gunshot injuries…

Continue ReadingRepair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons

Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons

  • Post author:
  • Post published:June 7, 2025
  • Post category:

Injuries to the spinal cord commonly result from motor vehicle accidents, traumatic falls, diving, surfing, skiing, and snowboarding accidents, other forms of sports injuries, as well as from gunshot injuries…

Continue ReadingRepair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons

Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell

  • Post author:
  • Post published:June 7, 2025
  • Post category:

Canavan disease is a devastating disease of infants which affects their neural development and leads to mental retardation and early death. It occurs in 1 in 6,400 persons in the…

Continue ReadingDeveloping a therapeutic candidate for Canavan disease using induced pluripotent stem cell

Crosstalk: Inflammation in Parkinson’s disease (PD) in a humanized in vitro model

  • Post author:
  • Post published:June 7, 2025
  • Post category:

Parkinson’s Disease (PD) is the most common neurodegenerative movement disorder. It is characterized by motor impairment such as slowness of movements, shaking and gait disturbances. Age is the most consistent…

Continue ReadingCrosstalk: Inflammation in Parkinson’s disease (PD) in a humanized in vitro model

Banking transplant ready dopaminergic neurons using a scalable process

  • Post author:
  • Post published:June 7, 2025
  • Post category:

Parkinson's disease (PD) is a devastating movement disorder caused by the death of dopaminergic neurons (a type of nerve cells in the central nervous system) present in the midbrain. These…

Continue ReadingBanking transplant ready dopaminergic neurons using a scalable process

New Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells

  • Post author:
  • Post published:June 7, 2025
  • Post category:

Spinal muscular atrophy (SMA) is the leading genetic cause of infant death in the U.S. This devastating disease affects 1 child in every 6,000-10,000 live births, with a North American…

Continue ReadingNew Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells

Developing a drug-screening system for Autism Spectrum Disorders using human neurons

  • Post author:
  • Post published:June 7, 2025
  • Post category:

Autism and autism spectrum disorders (ASD) are complex neurodevelopmental diseases that affect 1 in 150 children in the United States. Such diseases are mainly characterized by deficits in verbal communication,…

Continue ReadingDeveloping a drug-screening system for Autism Spectrum Disorders using human neurons
  • Go to the previous page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 34
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us